Stockreport

Disc Medicine Reports Third Quarter 2025 Financial Results and Provides Business Update

Disc Medicine, Inc.  (IRON) 
PDF Submitted a New Drug Application (NDA) for accelerated approval of bitopertin in erythropoietic protoporphyria (EPP) on September 29, 2025; Awarded the FDA Commissioner’ [Read more]